NO773134L - Fremgangsmaate ved fremstilling av antitumormiddel - Google Patents
Fremgangsmaate ved fremstilling av antitumormiddelInfo
- Publication number
- NO773134L NO773134L NO773134A NO773134A NO773134L NO 773134 L NO773134 L NO 773134L NO 773134 A NO773134 A NO 773134A NO 773134 A NO773134 A NO 773134A NO 773134 L NO773134 L NO 773134L
- Authority
- NO
- Norway
- Prior art keywords
- production
- leukemia
- agent
- tumor
- fighting agent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 18
- 239000002246 antineoplastic agent Substances 0.000 title claims description 3
- 238000002360 preparation method Methods 0.000 title description 3
- 208000032839 leukemia Diseases 0.000 claims description 18
- 206010028980 Neoplasm Diseases 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 8
- 241000191963 Staphylococcus epidermidis Species 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 230000000259 anti-tumor effect Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000002808 molecular sieve Substances 0.000 claims description 4
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 4
- 230000000274 adsorptive effect Effects 0.000 claims description 3
- 238000004255 ion exchange chromatography Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims 5
- 229910017464 nitrogen compound Inorganic materials 0.000 claims 4
- 150000002830 nitrogen compounds Chemical class 0.000 claims 4
- 239000000063 antileukemic agent Substances 0.000 claims 2
- 238000009630 liquid culture Methods 0.000 claims 2
- 239000000243 solution Substances 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 5
- 241000191940 Staphylococcus Species 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000002329 infrared spectrum Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 241000700605 Viruses Species 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007937 lozenge Substances 0.000 description 3
- 238000002211 ultraviolet spectrum Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 150000007514 bases Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JVIPLYCGEZUBIO-UHFFFAOYSA-N 2-(4-fluorophenyl)-1,3-dioxoisoindole-5-carboxylic acid Chemical compound O=C1C2=CC(C(=O)O)=CC=C2C(=O)N1C1=CC=C(F)C=C1 JVIPLYCGEZUBIO-UHFFFAOYSA-N 0.000 description 1
- 241000193798 Aerococcus Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 229920001425 Diethylaminoethyl cellulose Polymers 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- -1 oral administration Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005723 virus inoculator Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/44—Staphylococcus
- C12R2001/45—Staphylococcus epidermidis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10964876A JPS5334914A (en) | 1976-09-13 | 1976-09-13 | Antitumor agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO773134L true NO773134L (no) | 1978-03-14 |
Family
ID=14515604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO773134A NO773134L (no) | 1976-09-13 | 1977-09-12 | Fremgangsmaate ved fremstilling av antitumormiddel |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4159321A (de) |
| JP (1) | JPS5334914A (de) |
| AR (1) | AR215143A1 (de) |
| AT (1) | AT349137B (de) |
| AU (1) | AU515706B2 (de) |
| BE (1) | BE858661A (de) |
| DE (1) | DE2741234C3 (de) |
| DK (1) | DK406977A (de) |
| ES (1) | ES462245A1 (de) |
| FI (1) | FI772677A (de) |
| FR (1) | FR2364033A1 (de) |
| GB (1) | GB1530846A (de) |
| HK (1) | HK69579A (de) |
| IL (1) | IL52893A (de) |
| MY (1) | MY8000102A (de) |
| NL (1) | NL7709987A (de) |
| NO (1) | NO773134L (de) |
| NZ (1) | NZ185160A (de) |
| PT (1) | PT67012B (de) |
| SE (1) | SE7710201L (de) |
| YU (1) | YU215077A (de) |
| ZA (1) | ZA775450B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5632492A (en) * | 1979-08-28 | 1981-04-01 | Mitsui Toatsu Chem Inc | Antitumor active substance, its preparation and pharmaceutical |
| EP0157371A3 (de) * | 1984-04-04 | 1988-03-23 | Peters, Georg, Dr. med. | Arzneimittel mit immunmodulierender und die Proliferation von malignen Zellen hemmender Wirkung und Verfahren zu seiner Herstellung |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3366540A (en) * | 1962-08-03 | 1968-01-30 | Health Education Welfare Usa | Antibiotic anti-tumor agents and method of producing same |
| US3625833A (en) * | 1970-01-23 | 1971-12-07 | James J Schaffer | Process for producing antiviral substance from staphylococcus organisms |
-
1976
- 1976-09-13 JP JP10964876A patent/JPS5334914A/ja active Pending
-
1977
- 1977-09-05 IL IL52893A patent/IL52893A/xx unknown
- 1977-09-06 US US05/830,746 patent/US4159321A/en not_active Expired - Lifetime
- 1977-09-06 AU AU28577/77A patent/AU515706B2/en not_active Expired
- 1977-09-08 PT PT67012A patent/PT67012B/pt unknown
- 1977-09-09 ES ES462245A patent/ES462245A1/es not_active Expired
- 1977-09-09 FI FI772677A patent/FI772677A/fi not_active Application Discontinuation
- 1977-09-09 YU YU02150/77A patent/YU215077A/xx unknown
- 1977-09-12 SE SE7710201A patent/SE7710201L/xx not_active Application Discontinuation
- 1977-09-12 NZ NZ185160A patent/NZ185160A/xx unknown
- 1977-09-12 NO NO773134A patent/NO773134L/no unknown
- 1977-09-12 NL NL7709987A patent/NL7709987A/xx not_active Application Discontinuation
- 1977-09-12 AR AR269163A patent/AR215143A1/es active
- 1977-09-12 ZA ZA00775450A patent/ZA775450B/xx unknown
- 1977-09-12 AT AT653777A patent/AT349137B/de not_active IP Right Cessation
- 1977-09-13 DK DK406977A patent/DK406977A/da not_active Application Discontinuation
- 1977-09-13 FR FR7727645A patent/FR2364033A1/fr not_active Withdrawn
- 1977-09-13 DE DE2741234A patent/DE2741234C3/de not_active Expired
- 1977-09-13 GB GB38218/77A patent/GB1530846A/en not_active Expired
- 1977-09-13 BE BE180878A patent/BE858661A/xx unknown
-
1979
- 1979-09-27 HK HK695/79A patent/HK69579A/xx unknown
-
1980
- 1980-12-30 MY MY102/80A patent/MY8000102A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5334914A (en) | 1978-03-31 |
| NL7709987A (nl) | 1978-03-15 |
| FI772677A (fi) | 1978-03-14 |
| YU215077A (en) | 1982-06-30 |
| BE858661A (fr) | 1978-01-02 |
| ATA653777A (de) | 1978-08-15 |
| HK69579A (en) | 1979-10-05 |
| US4159321A (en) | 1979-06-26 |
| ZA775450B (en) | 1978-08-30 |
| DE2741234B2 (de) | 1979-07-05 |
| MY8000102A (en) | 1980-12-31 |
| ES462245A1 (es) | 1979-07-16 |
| DE2741234A1 (de) | 1978-03-16 |
| IL52893A (en) | 1980-07-31 |
| FR2364033A1 (fr) | 1978-04-07 |
| AR215143A1 (es) | 1979-09-14 |
| SE7710201L (sv) | 1978-03-14 |
| IL52893A0 (en) | 1977-11-30 |
| NZ185160A (en) | 1979-08-31 |
| DK406977A (da) | 1978-03-14 |
| PT67012A (en) | 1977-10-01 |
| AU2857777A (en) | 1979-03-15 |
| GB1530846A (en) | 1978-11-01 |
| PT67012B (en) | 1979-02-13 |
| DE2741234C3 (de) | 1980-03-20 |
| AU515706B2 (en) | 1981-04-16 |
| AT349137B (de) | 1979-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Grein et al. | Growth characteristics and antibiotic production of actinomycetes isolated from littoral sediments and materials suspended in sea water | |
| Weiner et al. | Characterization of a marine bacterium associated with Crassostrea virginica (the eastern oyster) | |
| NO149239B (no) | Offshore-konstruksjon. | |
| Waksman | Species concept among the actinomycetes with special reference to the genus Streptomyces | |
| JPS608117B2 (ja) | 新生理活性物質エステラスチンおよびその製造法 | |
| Techaoei et al. | Chemical evaluation and antibacterial activity of novel bioactive compounds from endophytic fungi in Nelumbo nucifera | |
| Kim et al. | Biological activity of L-2-azetidinecarboxylic acid, isolated from Polygonatum odoratum var. pluriflorum, against several algae | |
| Gohain et al. | Phylogenetic affiliation and antimicrobial effects of endophytic actinobacteria associated with medicinal plants: prevalence of polyketide synthase type II in antimicrobial strains | |
| NO773134L (no) | Fremgangsmaate ved fremstilling av antitumormiddel | |
| CN110951620B (zh) | 抗幽门螺旋杆菌活性的化合物及其制备方法和应用 | |
| Kuncharoen et al. | Diversity and antimicrobial activity of endophytic actinomycetes isolated from plant roots in Thailand | |
| CN107603922B (zh) | 海绵共生链霉菌及其发酵生产星形孢菌素的方法和应用 | |
| EP0059918B1 (de) | Mutastein, physiologisch wirksamer Stoff und Verfahren zu dessen Herstellung | |
| KR810000552B1 (ko) | 항악성 종양제의 제조방법 | |
| DK172686B1 (da) | Landbrugskemikalium kaldet ''stof nr. 51262'', samt fremgangsmåde til dets fremstilling | |
| CN102408998B (zh) | 一种具有神经退行性疾病防治活性的海洋红树耐盐性内生真菌 | |
| US4495286A (en) | Antibiotic complex producing bacterial culture | |
| Nurunnabi et al. | Sonneratinone: A new antimicrobial benzofuranone derivative from the endophytic fungus Aspergillus niger isolated from the mangrove plant Sonneratia apetala Buch.-Ham | |
| CN1037526C (zh) | 康乐霉素c的生产方法 | |
| US3711605A (en) | Antibiotic a150a | |
| Woodruff | Natural Products From Microorganisms An Odyssey Revisited | |
| Alwan | Effect of some Ricinus communis secondary metabolites on Phytophthora infestans and Fusarium solani | |
| US3617448A (en) | Antibiotic and methods of producing and using it | |
| Usup | The physiology and toxicity of the red tide dinoflagellate Pyrodinium bahamense var. compressum | |
| CN116283727A (zh) | 一种chaetoglobosin类化合物及其制备方法和应用 |